Procalcitonin: Clinical Trials

36 trials of Procalcitonin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 6 unknown, 3 recruiting, 3 terminated. 20 Not applicable, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable20Completed 12, Unknown 3, Terminated 2, Withdrawn 2, Recruiting 1
Phase 31Completed 1
Phase 41Terminated 1

Follow Procalcitonin: new trials by email Literature Review of Procalcitonin trials Research Report on Procalcitonin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison Between Interleukin 6 and Procalcitonin in Detecting Sepsis and Incidence of Mortality in Burn ICU Patients
Interleukin 6 - Burns, Sepsis
Not applicableRecruitingAin Shams University702025-01-102025-04-08
Procalcitonin as a Marker of Severity of Non-cystic Fibrosis Bronchiectasis in Children
procalcitonin - Non-cystic Fibrosis Bronchiectasis
UnknownAssiut University302024-07-012024-04-17
Role of PCO2 Gap as Predictor of Clinical Outcome in ICU Septic Patients
measurement of serum lactate and procalcitonin and PCO2 gap - Sepsis
UnknownAin Shams University802024-02-012024-02-13
Early Detection of At-risk Septic Patients
Measuring tissue oxygenation, Procalcitonin, Mid-regional proadrenomedullin - Sepsis
RecruitingUniversity Hospital Southampton NHS Foundation Trust602024-01-122024-12-02
Use of Procalcitonin, a Blood Test to Guide Antibiotic Therapy for Sepsis in Adults
Procalcitonin measurement - Sepsis
Phase 3CompletedUniversity of Oxford5322023-07-262026-09-22
PROcalcitonin and Presepsin-guided Decision for Antibiotic Prophylaxis of EOS
Procalcitonin/Presepsin guided antibiotic prophylaxis for EOS, Antibiotic prophylaxis for EOS - Early-Onset Neonatal Sepsis
Not applicableUnknownUniversity of Florence2662023-04-012023-04-03
Comparison of Procalcitonin Level in Normal Population and in Chronic Kidney Disease Patients Who Don't Have Infection
procalcitonin - Chronic Kidney Disease Patients Who Don't Have Infection
Not applicableUnknownSohag University502022-11-012022-10-19
Occurrence of Antibodies Cross-reacting With Autoantigens in Primary EBV Infection
Data collection: Participant characteristics (Illness course, complications of primary EBV infection and provided treatments), Data collection: blood samples (analysed for EBV serology, auto-antibody-testing/biobanking, RNA expression analyses, procalcitonin), Data collection: Patient reported outcome (Fatigue questionnaires) - Epstein-Barr Virus (EBV) Infection
RecruitingUniversity Hospital, Basel, Switzerland802021-10-152025-02-25
PCT-guided Treatment Regarding Antibiotic Use for Acute COPD Exacerbations
Procalcitonin, Physician's decision - COPD Exacerbation, COPD
Not applicableCompletedErasmus Medical Center6932021-08-102026-08-13
Combined Use of a Respiratory Broad Panel Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Hospitalized Sickle-cell Adults With Acute Chest Syndrome.
Intervention: Combined use of a respiratory broad panel multiplex PCR and procalcitonin, Control: usual antibiotic treatment - Acute Chest Syndrome, Sickle Cell Disease
Not applicableCompletedAssistance Publique - Hôpitaux de Paris722020-06-022025-03-24
PROcalcitonin Impact on Antibiotic Reduction, adverSe Events and AVoidable healthcarE Costs (ProSAVE): A RCT
procalcitonin - Pneumonia, Bacterial
Not applicableCompletedMassachusetts General Hospital7002020-05-282025-03-20
Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia
Combined use of a respiratory broad panel multiplex PCR and procalcitonin, Usual antibiotic treatment - Covid19, Pneumonia
Not applicableCompletedAssistance Publique - Hôpitaux de Paris1942020-04-202021-08-03
The Procalcitonin Guided Antibiotics in Respiratory Infections in General Practice
Procalcitonin - Acute Respiratory Tract Infection
Not applicableWithdrawnChronic Obstructive Pulmonary Disease Trial Network, Denmark2020-02-272023-03-27
Role and Value of Inflammatory Markers in Brain Tumors : A Case Controlled Study
Procalcitonin - Brain Tumor
CompletedUniversitas Sumatera Utara352020-01-012020-11-18
An Algorithm to Decide on Antibiotic Prescription in Lower Respiratory Tract Infection in Primary Care
UltraPro, Procalcitonin, Blood sampling - Lower Resp Tract Infection
Not applicableCompletedCentre Hospitalier Universitaire Vaudois4692018-09-012020-07-17
HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients With Suspected Infections: a Multicenter Pilot Study
HostDx Sepsis - Respiratory Tract Infections, Urinary Tract Infections
CompletedInflammatix5852018-07-232021-12-03
Evaluation of Procalcitonin (PCT) as a Marker of Infection Post Living Donated Liver Transplant
procalcitonin - Liver Transplant Infection
CompletedNational Hepatology & Tropical Medicine Research Institute602018-03-152021-03-19
Evaluation of the Roche Liat Flu/RSV Assay for Management of Influenza in the Emergency Department
Procalcitonin, Pharmacist-Led Education - Influenza, Human
Not applicableCompletedUniversity of California, Davis2002018-03-062023-10-17
Procalcitonin-guided Antibiotic Therapy During Severe Exacerbation of COPD
procalcitonin - Acute Exacerbation Copd
Not applicableUnknownUniversity Hospital, Mahdia1002017-10-052019-05-13
Predicting the Severity of Post-cesarean Wound Infections Using Serum Procalcitonin Levels
procalcitonin level - Wound Infection, Cesarean Wound Disruption
CompletedKanuni Sultan Suleyman Training and Research Hospital902017-05-022017-10-24

Showing 20 of 36. Sign in to see all of them.

Conditions studied

Sepsis (8)  ·  Infections (3)  ·  Pneumonia (3)  ·  Bacterial Infections (2)  ·  Disease (2)  ·  Intraabdominal Infections (2)  ·  Premature Birth (2)  ·  Pulmonary Disease, Chronic Obstructive (2)  ·  Acute Chest Syndrome (1)  ·  Anemia, Sickle Cell (1)  ·  Brain Diseases (1)  ·  Brain Neoplasms (1)  ·  Bronchiectasis (1)  ·  Bronchitis (1)  ·  Burns (1)

Sponsors

Ain Shams University (2)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Erasmus Medical Center (2)  ·  Ain Shams Maternity Hospital (1)  ·  Assiut University (1)  ·  Bangkok Metropolitan Administration Medical College and Vajira Hospital (1)  ·  Brahms AG (1)  ·  Brahms France (1)  ·  CAMC Health System (1)  ·  Centre Hospitalier Departemental Vendee (1)  ·  Centre Hospitalier Universitaire Vaudois (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Charite University, Berlin, Germany (1)  ·  Chronic Obstructive Pulmonary Disease Trial Network, Denmark (1)  ·  Federal University of Minas Gerais (1)

Countries

United States (6)  ·  France (5)  ·  Egypt (4)  ·  Netherlands (4)  ·  Brazil (2)  ·  Denmark (2)  ·  Germany (2)  ·  Spain (2)  ·  Switzerland (2)  ·  Bangladesh (1)  ·  Greece (1)  ·  Indonesia (1)  ·  Norway (1)  ·  Thailand (1)  ·  Tunisia (1)

Top investigators

Ahilanandan Dushianthan, PhD (1)  ·  Ahmed H Elsayed, M.B.B.CH (1)  ·  Alan Maisel, MD (1)  ·  Alev Atis, MD,ObGyn (1)  ·  Andreas Meisel, MD (1)  ·  Arjen Dondorp, Professor (1)  ·  David T Huang, MD MPH (1)  ·  Djillali Annane, Professor (1)  ·  Douglas W Haden, MD (1)  ·  Henrique NS Bittencourt, PhD (1)  ·  James N Ward, BM (1)  ·  Larissa S May, MD (1)

Results publications

PMID 10519716, PMID 10835436, PMID 10959733, PMID 11014424, PMID 11229684, PMID 12147798, PMID 12601102, PMID 1357073, PMID 14987884, PMID 17431204, PMID 17478736, PMID 18379262, PMID 18650914, PMID 19049549, PMID 19493352, PMID 19738090, PMID 21283001, PMID 21720792, PMID 21920453, PMID 22925000, PMID 23780645, PMID 24202395, PMID 24281089, PMID 24320627, PMID 24793958, PMID 25666772, PMID 27384242, PMID 27397086, PMID 27592364, PMID 27746396, PMID 28092374, PMID 28105073, PMID 28484421, PMID 28851296, PMID 29202730, PMID 29514604, PMID 29781385, PMID 29804483, PMID 31387559, PMID 32098866, PMID 33280547, PMID 34548312, PMID 35279069, PMID 36658543, PMID 37169498, PMID 39995490, PMID 42724645, PMID 7482646, PMID 8094770, PMID 8280464

NIH funding

R01GM101197 (1)